European public health agencies are preparing to test a new digital platform intended to help countries record, assess and coordinate information about emerging health threats. The system, called Epi+, is scheduled to begin rolling out in nine pilot countries in 2027, according to an update from the European Centre for Disease Prevention and Control (ECDC).

ECDC and Italy’s Istituto Superiore di Sanità held a training session in Rome in November 2026 for 40 national epidemiologists and technical experts. The training is part of the preparation for the pilot phase, rather than evidence that the platform is already operating across Europe.

What Epi+ is designed to do

Epi+ is described as a multilingual event-based surveillance platform. Event-based surveillance looks for signals of possible public health importance—such as reports of unusual disease patterns or other emerging threats—so that trained teams can review and assess them.

The platform is intended to give national authorities a shared digital environment for three linked tasks: recording potential public health events, assessing their significance, and coordinating information among the institutions involved in a national response. ECDC says many EU and European Economic Area countries do not currently have a dedicated national tool that covers this entire process.

That gap matters because emerging threats rarely arrive as a complete, neatly labelled dataset. Early information can be fragmented, uncertain and distributed across laboratories, healthcare services, local authorities and other agencies. A structured platform can help teams document what is known, identify what still needs verification and preserve an auditable record of decisions.

Why multilingual design matters

A multilingual system can reduce friction when teams work in different national and institutional settings. It may also support more consistent terminology and workflows, particularly during cross-border events. However, language support alone does not make surveillance data comparable. Countries still need agreed definitions, trained staff, reliable reporting channels and clear governance for how information is entered, corrected and shared.

For that reason, the 2027 pilot should be viewed as an implementation test. The important questions will include whether the platform fits national workflows, how quickly users can learn it, how well it supports collaboration across agencies and whether it improves the timeliness and quality of assessments.

A tool for experts, not an automated warning system

Epi+ should not be understood as a consumer alert service or as an autonomous system that decides whether an outbreak exists. Event-based surveillance depends on professional judgement. Signals must be verified, placed in context and assessed alongside laboratory, clinical and epidemiological evidence.

Digital tools can make that process more organised, but they cannot remove uncertainty from early-stage information. Nor can they replace laboratory capacity, field investigation, routine surveillance or direct communication between public health authorities.

Data governance will be central

Any platform handling sensitive public health information needs strong rules for access, security, retention and accountability. National authorities will need to define who can enter or view information, how corrections are documented, and when data may be shared beyond the institution or country that first recorded it.

The public ECDC update does not provide a complete technical or governance specification. Those details will be important during the pilot phase, particularly where event records could include identifiable or operationally sensitive information. A successful rollout will therefore depend as much on governance and training as on software features.

What to watch during the pilot

The pilot countries will provide an opportunity to test Epi+ in different public health systems. Useful measures of success could include the time needed to record and triage a signal, the completeness of event records, user adoption, cross-agency collaboration and the ability to trace how an assessment changed as new evidence arrived.

It will also be important to document where the platform adds work instead of reducing it. If national teams must enter the same information into several systems, the benefit could be limited. Integration with existing surveillance and reporting infrastructure will therefore be a practical concern.

Epi+ is a promising attempt to strengthen the digital foundations of public health preparedness. Its value, however, will be established through careful testing in real national settings—not by the platform’s launch alone.

Source: European Centre for Disease Prevention and Control, 11 November 2026. This article is an independent editorial summary of the public ECDC update.